Search Results 1-10 of 15968 for SC
Blumenthal, M.D., M.Sc. Allergist-Immunologist. Request an Appointment · Overview. Departments. Pulmonary Medicine · Allergic Diseases. Location. Jacksonville ...
In Part B (dose expansion), potential therapeutic doses may be studied with SC-004 as monotherapy and SC-004 in combination with ABBV-181 in disease-specific ...
This is a multicenter, open-label, Phase 1 study in participants with colorectal cancer (CRC) or gastric cancer to study the safety and tolerability of SC ...
Irritable bowel syndrome and chronic constipation. These conditions account for 25 percent of all patients presenting to gastroenterologists. Dr. Camilleri ...
About this study. The purpose of this study is to demonstrate the efficacy non-inferiority between isatuximab SC and isatuximab IV in combination with ...
SC-003 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody linked to a potent chemotherapy. Participation eligibility. Participant ...
Blumenthal, M.D., M.Sc., is a clinician-investigator in allergy and immunology. She focuses on improving population health and patient safety through ...
Part A (dose regimen finding) will involve dose escalation and possible dose interval modification to define the maximum tolerated dose (MTD) and/or recommended ...
Secondary objectives include efficacy measures of efgartigimod PH20 SC in participants with IIM. IIM is a disease of the immune system that causes weakness of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.